Raising Health Transforming Clinical Trials with Alexander Saint-Amand
42 snips
Jan 28, 2025 Alexander Saint-Amand, cofounder and CEO of Topography, is on a mission to break down barriers to accessing clinical trials, inspired by his personal experiences. He discusses the significant challenges patients face, including physician participation issues and systemic inefficiencies. Highlighting the importance of community clinics, he proposes a hybrid approach that blends technology with hands-on support. Additionally, he envisions a future where research is integrated into standard care, fostering greater diversity in trials and speeding up drug development.
AI Snips
Chapters
Transcript
Episode notes
GLG's Origin
- Alexander Saint-Amand's mother's illness inspired GLG, initially intended as a second medical opinion platform.
- This was due to the difficulty in diagnosing her illness, even after consulting numerous specialists.
Clinical Trial Accessibility
- Clinical trials face a significant access challenge, with many Americans living far from trial sites.
- Less than 5% of cancer patients enroll, highlighting a critical gap in access.
Access Challenges
- Despite access to GLG's network, Alexander Saint-Amand's CFO struggled to find a local trial for his cancer.
- This personal experience further fueled his drive to improve clinical trial access.